clonidine has been researched along with esmolol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Fisher, GC; Perks, D | 1 |
| Burton, MD; Johnson, DC; Kazemi, H | 1 |
| Franz, DN; Tseng, J; Wong, KC | 1 |
| Daniel, M; Eger, EI; Larson, MD; Noorani, M; Weiskopf, RB | 1 |
| Daniel, M; Eger, EI; Noorani, M; Weiskopf, RB | 1 |
| Campagni, MA; Howie, MB; McSweeney, TD; White, PF | 1 |
| Marik, PE; Varon, J | 1 |
| Pasch, T; Seifert, B; Spahn, DR; Szelloe, P; Zalunardo, MP; Zollinger, A | 1 |
| Bermejo, S; Fernandez-Galinski, S; Mansilla, R; Pol, O; Puig, MM | 1 |
| Bissell, BD; Ferreira, JA | 1 |
4 review(s) available for clonidine and esmolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of alpha2-agonist and beta-adrenergic blocker.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Clonidine; Humans; Propanolamines | 1989 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Catecholamines; Clonidine; Dexmedetomidine; Humans; Propanolamines; Sepsis; Shock, Septic; Stroke Volume; Sympathetic Nervous System; Sympatholytics; Tachycardia | 2018 |
4 trial(s) available for clonidine and esmolol
| Article | Year |
|---|---|
Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans.
Topics: Adrenergic beta-Antagonists; Anesthesia, Inhalation; Anesthetics; Blood Pressure; Chromatography, High Pressure Liquid; Clonidine; Desflurane; Dose-Response Relationship, Drug; Epinephrine; Fentanyl; Heart Rate; Humans; Injections, Intravenous; Isoflurane; Male; Norepinephrine; Propanolamines; Vasopressins | 1994 |
Comparative effects of oral clonidine and intravenous esmolol in attenuating the hemodynamic response to epinephrine injection.
Topics: Administration, Intranasal; Administration, Oral; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Analysis of Variance; Clonidine; Double-Blind Method; Epinephrine; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Propanolamines | 1999 |
[Cardiovascular stress protection following anesthesia induction. Comparison of clonidine and esmolol].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Anesthesia; Clonidine; Double-Blind Method; Female; Hemodynamics; Humans; Intraoperative Period; Male; Middle Aged; Propanolamines; Stress, Physiological | 2001 |
Comparative assessment of the effects of alfentanil, esmolol or clonidine when used as adjuvants during induction of general anaesthesia.
Topics: Adjuvants, Anesthesia; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Alfentanil; Analgesics; Anesthesia, General; Anesthetics, Intravenous; Blood Pressure; Clonidine; Double-Blind Method; Electroencephalography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Propanolamines | 2004 |
10 other study(ies) available for clonidine and esmolol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Esmolol and clonidine--a possible interaction.
Topics: Adrenergic beta-Antagonists; Bradycardia; Clonidine; Drug Interactions; Humans; Male; Propanolamines | 1992 |
Adrenergic and cholinergic interaction in central ventilatory control.
Topics: Acetylcholine; Animals; Atropine; Cardiovascular Physiological Phenomena; Cardiovascular System; Clonidine; Colforsin; Cyclic AMP; Dogs; Isoproterenol; Medulla Oblongata; Propanolamines; Receptors, Adrenergic; Receptors, Cholinergic; Respiration; Respiratory Center; Second Messenger Systems; Yohimbine | 1990 |
Fentanyl, clonidine, and repeated increases in desflurane concentration, but not nitrous oxide or esmolol, block the transient mydriasis caused by rapid increases in desflurane concentration.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Antagonists; Adult; Anesthetics, Inhalation; Blood Pressure; Clonidine; Desflurane; Drug Interactions; Epinephrine; Fentanyl; Heart Rate; Humans; Injections, Intravenous; Isoflurane; Male; Nitrous Oxide; Propanolamines; Pupil; Reflex, Pupillary; Sympathetic Nervous System | 1995 |